|
| 37380166 | Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients. | J Infect Dis | 2024 |
| 38009954 | COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. | Microbiol Spectr | 2024 |
| 38095433 | Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". | mBio | 2024 |
| 36268708 | Absence of pathogenic viruses in COVID-19 convalescent plasma. | Transfusion | 2023 |
| 37594966 | Examining sociodemographic correlates of opioid use, misuse, and use disorders in the All of Us Research Program. | PLoS One | 2023 |
| 37659419 | Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. | Lancet Microbe | 2023 |
| 37697938 | Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies. | J Infect Dis | 2023 |
| 37741499 | Impact of subgroup-specific heterogeneities and dynamic changes in mortality rates on forecasted population size, deaths, and age distribution of persons receiving antiretroviral treatment in the United States: a computer simulation study. | Ann Epidemiol | 2023 |
| 37534607 | Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials. | Transfusion | 2023 |
| 37724870 | Early antibody treatment, inflammation, and risk of post-COVID conditions. | mBio | 2023 |
| 35579509 | Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. | Clin Infect Dis | 2023 |
| 36987595 | Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample. | Clin Infect Dis | 2023 |
| 37434383 | The association of a scholarly concentrations program with medical students' matched residencies. | Med Educ Online | 2023 |
| 37131659 | Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial. | medRxiv | 2023 |
| 36722044 | Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial. | J Infect Dis | 2023 |
| 36478076 | A Growing Number of Men Who Have Sex With Men Aging With HIV (20212031): A Comparison of Two Microsimulation Models. | J Infect Dis | 2023 |
| 36922393 | Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. | Am J Epidemiol | 2023 |
| 36476571 | Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIV. | J Acquir Immune Defic Syndr | 2023 |
| 36541641 | The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017. | AIDS | 2023 |
| 36541638 | The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum. | AIDS | 2023 |
| 36398985 | Achieving a Representative Sample of Asian Americans in Biomedical Research Through Community-Based Approaches: Comparing Demographic Data in the <i>All of Us</i> Research Program With the American Community Survey. | J Transcult Nurs | 2023 |
| 36740590 | Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019. | Clin Infect Dis | 2023 |
| 36799620 | Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey. | Am J Epidemiol | 2023 |
| 36730830 | Telemedicine Use Among People With HIV in 2021: The Hybrid-Care Environment. | J Acquir Immune Defic Syndr | 2023 |
| 36824860 | Early Treatment, Inflammation and Post-COVID Conditions. | medRxiv | 2023 |
| 36631171 | Reply to Steele et al. | Clin Infect Dis | 2023 |
| 36861341 | Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout. | Clin Infect Dis | 2023 |
| 36594946 | Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. | JAMA | 2023 |
| 34711737 | Telemedicine and visit completion among people with HIV during the coronavirus disease 2019 pandemic compared with prepandemic. | AIDS | 2022 |
| 35617019 | Time Between Viral Loads for People With HIV During the COVID-19 Pandemic. | J Acquir Immune Defic Syndr | 2022 |
| 35353960 | Early Outpatient Treatment for Covid-19 with Convalescent Plasma. | N Engl J Med | 2022 |
| 35352362 | How do I implement an outpatient program for the administration of convalescent plasma for COVID-19? | Transfusion | 2022 |
| 35443020 | Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern. | Blood Adv | 2022 |
| 35705318 | Designing an electronic medical record alert to identify hospitalised patients with HIV: successes and challenges. | BMJ Health Care Inform | 2022 |
| 35671054 | Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States. | JAMA Netw Open | 2022 |
| 36445705 | Analysis of Clinical Outcomes of Pregnant Patients Treated With Nirmatrelvir and Ritonavir for Acute SARS-CoV-2 Infection. | JAMA Netw Open | 2022 |
| 36314809 | The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox. | mBio | 2022 |
| 36173112 | Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence. | mSphere | 2022 |
| 36227594 | Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US. | JAMA Netw Open | 2022 |
| 36053091 | Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation. | J Acquir Immune Defic Syndr | 2022 |
| 36048778 | An Overview of Cancer in the First 315,000 All of Us Participants. | PLoS One | 2022 |
| 34878432 | Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD. | J Acquir Immune Defic Syndr | 2022 |
| 35304844 | Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. | Lancet HIV | 2022 |
| 35294480 | Epidemiology of atrial fibrillation in the All of Us Research Program. | PLoS One | 2022 |
| 35104245 | Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection. | JCI Insight | 2022 |
| 34609485 | Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America. | Clin Infect Dis | 2022 |
| 34750289 | The shifting age distribution of people with HIV using antiretroviral therapy in the United States. | AIDS | 2022 |
| 34627998 | Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States. | Ann Epidemiol | 2022 |
| 32139207 | Resource utilization across the continuum of HIV care: An emergency department-based cohort study. | Am J Emerg Med | 2021 |
| 33710020 | Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. | AIDS | 2021 |